Tezspire 210 MG/1.91 ML syring 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FKNGP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,031
Award facts
- Contract value 100% obligated
- $7,030.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,030.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal contract awards encompassing a wide spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current delivery order for Tezspire—a biologic medication used in respiratory disease treatment—reflects the company's continued role in fulfilling specialized pharmaceutical requirements for the Department of Defense's healthcare network.
Quick answers
Who was awarded contract SPE2DB25FKNGP?
SPE2DB25FKNGP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FKNGP worth?
The government has obligated $7,031 on SPE2DB25FKNGP.
Is contract SPE2DB25FKNGP an order under another contract?
Yes. SPE2DB25FKNGP is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKNGP competed?
The extent of competition for SPE2DB25FKNGP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award